Jogen Atone
Jogen is a Principal with Catalys Pacific. Previously a Market Access Consultant at ZS Associates, he supported the launch of more than 20 products across oncology, neurology, metabolic, immunology, and rare disease areas in Japan and the broader APAC region. His work spanned product-level pricing and market access strategy, as well as analysis of policy trends and industry positions related to Japan’s drug pricing system reforms.
Earlier in his career, he conducted preclinical research at the University of California, Davis, contributing to the evaluation of novel Parkinson’s disease compounds that have since advanced into clinical development. He brings experience spanning early drug discovery through the clinical development continuum.
He holds a B.S. in Neuroscience from Trinity University and an M.S. in Pharmacology and Toxicology from the University of California, Davis.
“Wherever the art of Medicine is loved, there is also a love of Humanity. ”